Oligopeptides – noted for their shorter chain length (two-six amino acids) – reportedly have rapid and superior digestibility while providing nutritional value, are water solubility, and are stable across a range of temperatures and pH.
A spokesperson for the company told us that the peptides can be used in multiple channels, including sports nutrition, personal care, medical foods, bariatric and meal replacement.
The Chinese National Research Institute for Food and Fermentation Industries (CNRIFFI) supports research of peptides and will work closely with Ancon and B&D. The peptides will be produced in a brand-new facility in Guangdong Province called Sino NutriFood.
“B&D was a natural choice to bring our peptides to the U.S. market. They have developed markets for other ingredients prior to this venture, and have the reputation and knowledge needed to duplicate what has been done in China and Japan,” said Chris Cai, Vice President/founder of Ancon.
Bill Van Dyke, president of B&D, added: “Working with Chris and Dachao Zhang and understanding the role and benefits of peptides make this one of the most exciting agreements we have ever entered into. The opportunity to represent Ancon across the U.S. further aligns our priorities and commitment to bringing valued brands to market.”
The agreement was announced at the recent 4th Annual International Conference on Food-Derived Peptides in China.